Jpmorgan Chase & Co »

Serina Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Serina Therapeutics (SER) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Serina Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Serina Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Serina Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-06-30 $105 11 9.55
2024-03-31 $13 1 13.00

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf (SPY)
Meta Platforms Common (META)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Broadcom Common (AVGO)
Alphabet Common (GOOGL)
Vanguard Total Intl Bond Etf Fund (BNDX)
Vanguard S&p 500 Etf idx (VOO)
Ishares Core S&p 500 Etf Fund (IVV)

View all positions for Jpmorgan Chase & Co

Top funds holding Serina Therapeutics

Broadwood Capital
Geode Capital Management
HighTower Advisors
Vanguard Group
Millennium Management
BlackRock
Tower Research Capital
Bank of America Corporation
Piscataqua Savings Bank
Riggs Asset Managment
Jpmorgan Chase & Co
Albion Financial Group
Pacifica Partners
Advisor Group Holdings
UBS Group

View all funds holding Serina Therapeutics